Increased prevalence of chronic rhinosinusitis with nasal polyps (CRSwNP) and an increase in the senior population, both of which are more prone to the development of chronic rhinosinusitis with nasal polyps, are the key drivers driving the expansion of the nasal polyps treatment market.
Furthermore, otorhinolaryngologic surgeons' increased use of minimally invasive operations, a large product pipeline for the Nasal Polyps Treatment Market, and increased research efforts all contribute to the market's growth. However, the high cost of sinus surgery, as well as problems such as excessive bleeding, cerebrospinal fluid leak, visual abnormalities, postoperative scarring, and inflammation, limit the market's expansion.
Furthermore, side effects associated with steroid therapy, including weight gain, loss of bone mineral density, and the formation of cataracts in the eyes, are projected to impede market expansion. Technological advancements in nasal polyps treatment, such as the availability of key technologies like nasal endoscopy and computerized tomography for nasal polyps treatment and diagnosis, on the other hand, are expected to provide lucrative growth opportunities for nasal polyps treatment market players.
Read More @ https://cmiinfopiece.blogspot.com/2022/01/nasal-polyps-treatment-market-rise-in.html
